Skip to main content
. 2021 Apr 22;11:630256. doi: 10.3389/fonc.2021.630256

Figure 1.

Figure 1

Patient’s imaging before and during anti-tumor treatment. (A) The baseline chest computed tomography (CT) scan before treatment. (B) Bone isotope scanning suggested extensive bone metastases after 12 months of Osimertinib treatment.